FLFei Luan

Fei Luan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fei Luan has a total of 126 co-authors. Here are the top co-authors by number of shared publications:

  • Nan Zeng

    State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    12 shared publications
  • Jing Sun

    Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research,Shanxi,CHINA. College of Pharmacy,Shanxi,CHINA. Shaanxi University of Chinese Medicine,Shanxi,CHINA

    9 shared publications
  • Junbo Zou

    Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an 712046, P.R. China

    9 shared publications
  • Junbo Zou

    School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, People’s Republic of China

    8 shared publications
  • Xiaofei Zhang

    Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an 712046, P.R. China

    7 shared publications
  • Yajun Shi

    Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an 712046, P.R. China

    7 shared publications

Latest Publications

  • Open Access

    Extraction, purification, structural features, and pharmacological properties of polysaccharides from Glycyrrhiza uralensis : a review

    by Jing Liu, Rui Wang, Si-Cheng Zhai, Dong-Dong Zhang, Xiao-Fei Zhang, Jing Sun, Fei Luan, Jun-Bo Zou

    Glycyrrhiza uralensis, known as “Gan-Cao” in Chinese, is one of the most widely used herbs in the world. As a long-established and widely used traditional Chinese medicine, G. uralensis has spleen and qi promoting, heat clearing and detoxifying effects and is listed in the pharmacopoeias of several countries. In recent years, the extraction, purification, biological activity, and applications of G. uralensis polysaccharides (GUPs) have attracted the attention of researchers. Studies have shown that GUPs possess various biological functions, including anti-inflammatory, immune regulation, antioxidant, anti-tumor, anti-diabetic, and antibacterial properties. Therefore, a comprehensive systematic review is needed to summaries the latest progress on GUPs and to promote a deeper understanding of their biological functions. This paper reviews the research progress of GUPs in terms of extraction and purification methods, chemical structure, biological activity, possible mechanisms of action and potential applications, providing valuable insights and the latest information for the further development and application of GUPs in fields such as medicine, feed additives, vaccination and food additives.

  • Open Access

    An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer

    by Ai-Jia Wang, Huan Tian, Zhan-Peng Wang, Jiang-Xue Cheng, Jing Sun, Feng Zhao, Ya-Jun Shi, Xiao-Fei Zhang, Jun-Bo Zou, Fei Luan, et al.

    Background: Colon cancer ranks as the third most common malignant tumor globally. Due to incomplete surgical resection and the multidrug resistance of tumor cells, it exhibits a high postoperative recurrence rate. Consequently, there is an urgent need to develop novel therapeutic strategies to inhibit postoperative recurrence of colon cancer. Methods: Thermosensitive liposomes (Bu&Ap-Lip) co-loaded with bufalin (Bu) and apatinib (Ap) were prepared via the thin-film hydration method, with optimization of Prescription Processes. Bu&Ap-Lip was co-encapsulated with new indocyanine green (IR820) within an injectable PLGA-PEG-PLGA hydrogel, establishing a photothermally responsive composite hydrogel (Bu&Ap-Lip@IR820 Gel). The system characterized the physicochemical properties, rheological characteristics, and drug release behavior of the hydrogel, and further evaluated its in vitro antitumor activity and in vivo efficacy against postoperative recurrence of colon cancer. Results: Bu&Ap-Lip@IR820 Gel demonstrated excellent injectability and photothermally responsive drug-release properties. In vitro cellular experiments demonstrated that Bu&Ap-Lip@IR820 Gel effectively inhibited tumor cell migration, invasion, and angiogenesis. In vivo studies revealed that this liposome hydrogel prolonged local drug retention. When combined with near-infrared light irradiation, Bu&Ap-Lip@IR820 Gel significantly suppressed tumor recurrence while exhibiting favorable in vivo biocompatibility. Conclusion: This study developed a NIR-responsive composite liposome hydrogel integrating Bu multi-targeted antitumor properties, Ap anti-angiogenic effects, and IR820 photothermal therapeutic advantages. Through near-infrared responsiveness, it achieves localized precision drug release, effectively suppressing postoperative recurrence. This provides a novel and promising strategy for the clinical prevention and treatment of colon cancer recurrence.


  • Cornus officinalis Sieb.: An updated review on the ethnopharmacology, phytochemistry, pharmacology, toxicology, and pharmacokinetics

    by Chunli Cui, Wenhao Liu, Lile Feng, Junbo Zou, Yajun Shi, Jing Sun, Xiaofei Zhang, Erhong Huo, Fei Luan, Mingliang Zhang


  • JoVE Video Dataset

    by Ziwen Lei, Xinyuan Cao, He Wang, Xiaoxiao Lin, Zhichao Wang, Kaixuan Zhang, Jiaxiang Rong, Yajun Shi, Junbo Zou, Fei Luan

    The myocardial ischemia-reperfusion injury (MI/RI) model is of great significance in exploring the pathophysiological mechanisms of myocardial infarction and facilitating the development of relevant drugs. However, among the commonly used modeling methods, the traditional polyethylene-tube-assisted coronary artery ligation method has significant drawbacks. It requires reopening the chest to untie the ligature, which is not only time-consuming but also causes substantial damage to the experimental animals and can easily lead to their death. The aim of this study is to introduce an improved model-preparation method. In this method, the Left Anterior Descending Coronary Artery (LAD) is ligated using a double live-knot coil, and the live-knot can be opened in vitro to achieve reperfusion, thus avoiding a second invasive procedure. Evaluation methods such as electrocardiogram (ECG) monitoring, M-mode echocardiography (ME) determination, Evans Blue and 2,3,5-triphenyte-trazoliumchloride staining (EB-TTC) showed that this method could induce stable MI/RI. This improved MI/RI model scheme is characterized by its simplicity and speed, and the modeling success rate is highly satisfactory. Overall, it offers practical and valuable guidance for researchers engaged in the field of MI/RI research.

  • A Minimally Invasive Double Live-Knot Technique for Myocardial Ischemia-Reperfusion Injury Modeling in Rats

    by Ziwen Lei, Xinyuan Cao, He Wang, Xiaoxiao Lin, Zhichao Wang, Kaixuan Zhang, Jiaxiang Rong, Yajun Shi, Junbo Zou, Fei Luan

    The myocardial ischemia-reperfusion injury (MI/RI) model is of great significance in exploring the pathophysiological mechanisms of myocardial infarction and facilitating the development of relevant drugs. However, among the commonly used modeling methods, the traditional polyethylene-tube-assisted coronary artery ligation method has significant drawbacks. It requires reopening the chest to untie the ligature, which is not only time-consuming but also causes substantial damage to the experimental animals and can easily lead to their death. The aim of this study is to introduce an improved model-preparation method. In this method, the Left Anterior Descending Coronary Artery (LAD) is ligated using a double live-knot coil, and the live-knot can be opened in vitro to achieve reperfusion, thus avoiding a second invasive procedure. Evaluation methods such as electrocardiogram (ECG) monitoring, M-mode echocardiography (ME) determination, Evans Blue and 2,3,5-triphenyte-trazoliumchloride staining (EB-TTC) showed that this method could induce stable MI/RI. This improved MI/RI model scheme is characterized by its simplicity and speed, and the modeling success rate is highly satisfactory. Overall, it offers practical and valuable guidance for researchers engaged in the field of MI/RI research.


  • Open Access

    Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer

    by Jia-Xin Qiao, Dong-Yan Guo, Huan Tian, Zhan-Peng Wang, Qiang-Qiang Fan, Yuan Tian, Jing Sun, Xiao-Fei Zhang, Jun-Bo Zou, Jiang-Xue Cheng, et al.


  • Ethnobotanical usages, phytochemistry, pharmacology, and quality control of chuanxiong rhizoma: A review

    by Jing Liu, Ziwen Lei, Zhichao Wang, He Wang, Jing Sun, Dongyan Guo, Fei Luan, Junbo Zou, Yajun Shi


  • Extraction, purification, structural features, and pharmacological properties of polysaccharides from Houttuynia cordata: A review

    by Jing Liu, Junbo Zou, Jingyuan Wang, Rui Wang, Sicheng Zhai, Xing Chang, Xiaofei Zhang, Jing Sun, Fei Luan, Yajun Shi


  • Open Access

    Research progress on the natural products in the intervention of myocardial infarction

    by Qiuting Guo, Jinhui Wang, Caixia Ni, Jiaojiao Pan, Junbo Zou, Yajun Shi, Jing Sun, Xiaofei Zhang, Deng Wang, Fei Luan

    Coronary heart disease is a prevalent cardiovascular ailment globally, with myocardial infarction (MI) being one of its most severe manifestations. The morbidity and mortality of MI are escalating, showing an increasing trend among younger, highly educated individuals, thereby posing a serious threat to public health. Currently, thrombolysis, percutaneous coronary intervention, and coronary artery bypass grafting are the primary clinical treatments for MI. Although these methods significantly reduce patient mortality, complications often result in poor prognoses. Due to limitations in chemical synthetic drug research, the focus has shifted towards developing herbs based on natural substances. Natural medicines represent a novel approach for safer and more effective MI management and treatment. They can control multiple pathogenic variables by targeting various pathways and systems. This paper investigates the molecular mechanisms of MI and evaluates the application of natural products and medicinal plants in MI treatment over the past 5 years, demonstrating their specific good therapeutic potential and superior tolerance. These natural therapies have been shown to mitigate myocardial cell damage caused by MI through mechanisms such as oxidative stress, inflammation, apoptosis, angiogenesis, myocardial fibrosis, autophagy, endoplasmic reticulum stress, mitophagy, and pyroptosis. This review offers the latest insights into the application of natural products and medicinal plants in MI treatment, elucidating their mechanisms of action and serving as an important reference for MI prevention.